Idhifa has been approved for the treatment of relapsed or refractory acute myeloid leukemia
Acute myeloid leukemia (AML) is an aggressive blood and bone marrow cancer where not all leukemic cells are destroyed...
leukemia
Acute myeloid leukemia (AML) is an aggressive blood and bone marrow cancer where not all leukemic cells are destroyed...